Patents by Inventor Joseph Chau

Joseph Chau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170044118
    Abstract: A salt compound, and methods for mitigating neurodegeneration, effecting, neuroprotection and/or effecting cognition enhancement in a subject using the salt compound are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic salt compound comprising, a nitrate ester.
    Type: Application
    Filed: July 15, 2015
    Publication date: February 16, 2017
    Inventors: Robert Bender, Ho-Lun Joseph CHAU, Doug Cowart
  • Patent number: 9114135
    Abstract: A salt compound, and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject using the salt compound are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic salt compound comprising a nitrate ester.
    Type: Grant
    Filed: August 24, 2011
    Date of Patent: August 25, 2015
    Assignee: SGC Pharma Inc.
    Inventors: Robert Bender, Ho-Lun Joseph Chau, Doug Cowart
  • Publication number: 20130245078
    Abstract: A salt compound, and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject using the salt compound are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic salt compound comprising a nitrate ester.
    Type: Application
    Filed: August 24, 2011
    Publication date: September 19, 2013
    Applicant: SGC PHARMA, INC.
    Inventors: Robert Bender, Ho-Lun Joseph Chau, Doug Cowart
  • Patent number: 7494610
    Abstract: A method of activating a zeolite membrane comprising a step of placing the membrane in contact with a fluid mixture containing ozone, wherein when the fluid mixture is a gaseous mixture, the fluid mixture has a temperature of at least 423K, and wherein when the fluid mixture is a liquid mixture, the fluid mixture has a temperature of 353K.
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: February 24, 2009
    Assignee: The Hong Kong University of Science and Technology
    Inventors: King Lun Yeung, Koon Fung Lam, Samuel Heng, Lik Hang Joseph Chau
  • Publication number: 20060211857
    Abstract: Steroid compounds having various oxygen substitution on the steroid nucleus are disclosed. A specific functionality present on many of the steroid compounds is oxygen substitution at both of positions 6 and 7. Thus, certain steroids have oxygen substitution at C6 and C7, and some have specific stereochemistries such as 6? and 7? oxygen substitution, and an alpha hydrogen at the 5 position in addition to having 6? and 7? oxygen substitution. Steroids having 3,4-epoxy functionality are also disclosed. In addition, steroids having C17 pyran and ?-lactone functionality, with oxygen substitution at C6 and C7, or at C15, of the steroid nucleus, are disclosed.
    Type: Application
    Filed: November 22, 2005
    Publication date: September 21, 2006
    Applicants: Inflazyme Pharmaceuticals Ltd., The University of British Columbia, The University of Alberta
    Inventors: David Burgoyne, Yaping Shen, John Langlands, Christine Rogers, Joseph Chau, Edward Piers, Hassan Salari